FDA User Fee Bill Easily Slides Through Senate

Law360, New York (May 24, 2012, 4:12 PM EDT) -- The U.S. Senate on Thursday overwhelmingly approved legislation authorizing the U.S. Food and Drug Administration to collect $2.8 billion in user fees from the drug and device industries, after a strenuous effort to keep controversial and anti-industry amendments, including one targeting pay-for-delay agreements, out of the bill.

The Senate passed its version of the bill in a 96-1 vote. The bill has enjoyed remarkable bipartisan support, flogged by the leaders of the Senate health committee, who worked for more than a year to write a series...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.